NCT06356103

Brief Summary

Purpose: Undernutrition is common in neurologically impaired children. It increases the burden of comorbidities and affects the quality of life of these children. This study aimed primarily to compare the efficacy of whey-based partially hydrolyzed formula (WPHF) versus isocaloric polymeric formula on the nutritional status reflected by growth parameters and feeding tolerance in undernourished children with neurological impairment (NI). The secondary aim was to follow up on the changes in these parameters after using WPHF for 3 and 6 months

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2023

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

March 16, 2024

Completed
25 days until next milestone

First Posted

Study publicly available on registry

April 10, 2024

Completed
Last Updated

August 19, 2024

Status Verified

February 1, 2022

Enrollment Period

7 months

First QC Date

March 16, 2024

Last Update Submit

August 16, 2024

Conditions

Keywords

Neurological ImpairmentChildrenPartially Hydrolyzed Formula

Outcome Measures

Primary Outcomes (4)

  • To compare the efficacy of whey-based partially hydrolyzed formula versus standard feeding on the weight in kilogram in undernourished children with neurological impairment (NI).

    Identify the Efficacy Of Whey-Based Partially Hydrolyzed Formula on the weight in Kilogram measured using the double weighing method (weight of the parent subtracted from the combined weight of parent and child) on a digital scale.

    6 months

  • To compare the efficacy of whey-based partially hydrolyzed formula versus standard feeding on the height/length in centimeter in undernourished children with neurological impairment (NI).

    Identify the Efficacy Of Whey-Based Partially Hydrolyzed Formula on the height/length in Centimeter measured by a stadiometer. In children with joint contractions, spasticity, and/or scoliosis, the length was measured by segmental length measurements using sliding calipers. Then the length was estimated by simple equations such as knee-heel length (L = (2.69 x KH) + 24.2), tibia length (L = (3.26 x TL) + 30.8).

    6 months

  • To compare the efficacy of whey-based partially hydrolyzed formula versus standard feeding on the body mass index (BMI) in children with neurological impairment (NI).

    Identify the Efficacy Of Whey-Based Partially Hydrolyzed Formula on the body mass index (BMI) calculated as \[weight in kg\]/ \[height in m\]2

    6 months

  • To compare the efficacy of whey-based partially hydrolyzed formula versus standard feeding on the head circumference in centimeter in undernourished children with neurological impairment (NI)

    Identify the Efficacy Of Whey-Based Partially Hydrolyzed Formula on the head circumference (HC) in Centimeter measured by non-stretchable tape

    6 months

Secondary Outcomes (4)

  • To follow up the efficacy of whey-based partially hydrolyzed formula versus standard feeding on the weight in kilogram in undernourished children with neurological impairment (NI) for 3 and 6 months

    6 months

  • To follow up the efficacy of whey-based partially hydrolyzed formula versus standard feeding on the height/length in Centimeter in undernourished children with neurological impairment (NI) for 3 and 6 months

    6 months

  • To follow up the efficacy of whey-based partially hydrolyzed formula versus on the body mass index in undernourished children with neurological impairment (NI) for 3 and 6 months

    6 months

  • To follow up the efficacy of whey-based partially hydrolyzed formula versus standard feeding on the head circumference in Centimeter in undernourished children with neurological impairment (NI) for 3 and 6 months

    6 months

Study Arms (2)

Group I

ACTIVE COMPARATOR

received 50% of their caloric requirements as isocaloric polymeric formula (standard ) and 50% standard nutritional feeding according to ESPGHAN guidelines

Dietary Supplement: received 50% of their caloric requirements as isocaloric polymeric formula (standard ) and 50% standard nutritional feeding according to ESPGHAN guidelines

Group II

ACTIVE COMPARATOR

received 50% of their caloric requirements as WPHF and the other 50% as standard nutritional feeding

Dietary Supplement: Whey-Based Partially Hydrolyzed Formula

Interventions

Peptamen junior, 100 kcal/100 ml (Nestlé Health Science, Vevey, Switzerland).

Group II

protein and micronutrient requirements according to the recommended dietary allowance (RDA)

Group I

Eligibility Criteria

Age2 Years - 6 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children aged from 2-6 years
  • undernourished children with NI (1 or more of the following signs for identification of undernutrition in the studied children:
  • weight for age z score \<-2,
  • triceps skinfold thickness \<10th centile for age,
  • mid-upper arm fat or muscle area \<10th percentile for age,
  • faltering weight
  • failure to thrive.
  • physical signs of undernutrition such as decubitus skin problems and poor peripheral circulation

You may not qualify if:

  • NI due to metabolic diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alexandria University Children Hospital

Alexandria, 23445, Egypt

Location

MeSH Terms

Conditions

Child Nutrition DisordersNervous System DiseasesNeurologic Manifestations

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: A Randomized Controlled Study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 16, 2024

First Posted

April 10, 2024

Study Start

June 1, 2022

Primary Completion

December 31, 2022

Study Completion

July 15, 2023

Last Updated

August 19, 2024

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations